This event is organised by Oxford Biotech
The Global Response to Ebola: Implications for Future Drug & Vaccine Development
3pm, 15th July 2015
Nelson Mandela Lecture Theatre, Saïd Business School, University of Oxford, OX1 1HP
The Ebola epidemic, which tore through West Africa in 2014, and continues to pose a huge global health challenge, has prompted unparalleled collaboration between academia, industry and government. This has led to the generation and trialing of new vaccine candidates at unprecedented rates.
Join us for what is certain to be an informative and enthralling discussion about how entrepreneurs, academics, industry professionals and governments can learn lessons from the collaborative approach used to fight Ebola, and how this can lead to revolutionary new approaches in drug discovery & development.
We are delighted to have secured the following speakers, whose contributions promise to make this an event of universal interest and one not to be missed:
Prof Dame Sally Davies
Chief Medical Officer, Chief Scientific Advisor to the Department of Health
Prof Adrian Hill
Director of the Jenner Institute, Infectious Diseases & Clinical Trials,
University of Oxford
Prof Peter Horby
Director of Oxford University Clinical Research Unit in Hanoi, Vietnam
Prof Miles Carroll
Head of Research & Microbiology Services, Public Health England
Dr W. Shawn Carbonell
Co-Founder & CEO, OncoSynergy, Inc.
Dr Adam Hacker
Global Regulatory Responsibilities: Ebola Vaccine & Treatment Projects, Crucell and Janssen,
Dr Marguerite Koutsoukos
Project Leader, HIV Vaccine Programme,
After the event there will be an opportunity to engage with our high-profile speakers and sponsors, in a less formal setting.
Don't miss this opportunity to join over 200 scientist and entrepreneurs for this major event. Attendance is FREE to all but prior registration is required (http://www.oxfordbiotech.org/event-ebola/)